Our weight loss program in Lakewood, New York uses GLP-1 medications including Ozempic, Mounjaro, Wegovy, Zepbound, and more to help patients lose weight and reach their goals under the guidance of a licensed provider
Providers can start using the new E-codes in combination with the existing Z-codes beginning October 1, 2024
The kidneys act as the bodys natural filters, removing waste and excess fluid from the blood
The medication is administered once weekly via subcutaneous injection, with doses typically initiated at 2.5 mg once weekly for 4 weeks, then escalated (e.g., to 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg) based on response and tolerability as per the SmPC